Capstone Triton Financial Group, LLC Pfizer Inc Transaction History

Capstone Triton Financial Group, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 17, 2023	BUY	$36.12 - $41.79 $30,665 - $35,479	849 Added 2.5%	34,749 $1.27 Million
Q1 2023 Apr 06, 2023	SELL	$39.39 - $51.28 $66,529 - $86,611	-1,689 Reduced 4.75%	33,900 $1.38 Million
Q4 2022 Jan 17, 2023	SELL	$41.75 - $54.5 $25,718 - $33,572	-616 Reduced 1.7%	35,589 $0
Q3 2022 Oct 28, 2022	BUY	$43.76 - $53.42 $16,847 - $20,566	385 Added 1.07%	36,205 $1.58 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $8,980 - $10,647	-193 Reduced 0.54%	35,820 $1.83 Million
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $1.65 Million - $2.04 Million	36,013 New	36,013 $1.79 Million
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $1.49 Million - $2.21 Million	-36,069 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $35,874 - $46,083	914 Added 2.6%	36,069 $1.56 Million
Q2 2021 Aug 09, 2021	BUY	$35.91 - $40.68 $83,598 - $94,703	2,328 Added 7.09%	35,155 $1.38 Million
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $14,735 - $16,618	-440 Reduced 1.32%	32,827 $1.19 Million
Q4 2020 Jan 28, 2021	BUY	$33.47 - $42.56 $1.11 Million - $1.42 Million	33,267 New	33,267 $1.23 Million

3,260

3.73B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Capstone Triton Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Capstone Triton Financial Group, LLC with notifications on news.